

The global Gentle Organic Infant Formula market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Gentle Organic Infant Formula 91ÖÆÆ¬³§.
According to World Bank statistics, the global birth rate in 2021 was about 1.7%. Although the population growth rate had slowed down, with the development of the world economy and the increase of per capita disposable income of residents, the spending power is growing. Therefore, there is still a large room for development in the baby products industry. Improving product quality and tapping the value of a single customer will become the drivers for the growth of the infant and child industry. Refinement and diversification are the core characteristics of the consumer demand. China has a large population base, and even if the population growth rate slows down, there will still be a demographic dividend. The State Council in 2022 proposes to "Guide market players to produce safer and healthier domestic infant products". According to the National Bureau of Statistics, China's birth rate in 2022 was 6.77%, and the birth population was 9.56 million. According to the results of the seventh national census in 2021, the number of infants and young children aged 0-6 in China reached 140 million, of which the number of infants and young children aged 3-6 exceeded 70 million. The huge population size has brewed a market demand with huge potential, and the children's consumption market has risen rapidly. Chinese families spend a lot on childcare, with the average cost of childcare ranking second in the world. The survey data released by China Research Center for Children's Industry shows that in 80% of families in China, children's expenditures account for 30% to 50% of household expenditures, and the average annual consumption of children in families is ¥17,000 to 25,500. According to data from the Yuwa Population Research, the national average cost of raising a child (the cost of raising a child to the age of 18) is ¥485,218. From the perspective of specific stages, the largest proportion is the cost of raising children aged 6-14, accounting for about 45%. The cost during pregnancy, the cost of childbirth and confinement, and the cost of raising babies aged 0-2 accounted for 2.06%, 2.09% and 13.33% separately.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Gentle Organic Infant Formula market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Abbott
HiPP
Holle
Bellamy
Topfer
Supermum
The Hain Celestial Group
Nature One
Perrigo
Babybio
Gittis
Humana
Bimbosan
Ausnutria
Nutribio
HealthyTimes
Arla
Angisland
Yeeper
Wyeth
Kendamil
Nestle
Feihe
JUNLEBAO
YILI
BIOSTIME
Biobim
Segment by Type
Wet Process Type
Dry Process Type
Segment by Application
First Stage
Second Stage
Third Stage
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Gentle Organic Infant Formula report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Gentle Organic Infant Formula Market Overview
1.1 Product Overview and Scope of Gentle Organic Infant Formula
1.2 Gentle Organic Infant Formula Segment by Type
1.2.1 Global Gentle Organic Infant Formula Market Value Comparison by Type (2023-2029)
1.2.2 Wet Process Type
1.2.3 Dry Process Type
1.3 Gentle Organic Infant Formula Segment by Application
1.3.1 Global Gentle Organic Infant Formula Market Value by Application: (2023-2029)
1.3.2 First Stage
1.3.3 Second Stage
1.3.4 Third Stage
1.4 Global Gentle Organic Infant Formula Market Size Estimates and Forecasts
1.4.1 Global Gentle Organic Infant Formula Revenue 2018-2029
1.4.2 Global Gentle Organic Infant Formula Sales 2018-2029
1.4.3 Global Gentle Organic Infant Formula Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Gentle Organic Infant Formula Market Competition by Manufacturers
2.1 Global Gentle Organic Infant Formula Sales Market Share by Manufacturers (2018-2023)
2.2 Global Gentle Organic Infant Formula Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Gentle Organic Infant Formula Average Price by Manufacturers (2018-2023)
2.4 Global Gentle Organic Infant Formula Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Gentle Organic Infant Formula, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Gentle Organic Infant Formula, Product Type & Application
2.7 Gentle Organic Infant Formula Market Competitive Situation and Trends
2.7.1 Gentle Organic Infant Formula Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Gentle Organic Infant Formula Players Market Share by Revenue
2.7.3 Global Gentle Organic Infant Formula Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Gentle Organic Infant Formula Retrospective Market Scenario by Region
3.1 Global Gentle Organic Infant Formula Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Gentle Organic Infant Formula Global Gentle Organic Infant Formula Sales by Region: 2018-2029
3.2.1 Global Gentle Organic Infant Formula Sales by Region: 2018-2023
3.2.2 Global Gentle Organic Infant Formula Sales by Region: 2024-2029
3.3 Global Gentle Organic Infant Formula Global Gentle Organic Infant Formula Revenue by Region: 2018-2029
3.3.1 Global Gentle Organic Infant Formula Revenue by Region: 2018-2023
3.3.2 Global Gentle Organic Infant Formula Revenue by Region: 2024-2029
3.4 North America Gentle Organic Infant Formula Market Facts & Figures by Country
3.4.1 North America Gentle Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Gentle Organic Infant Formula Sales by Country (2018-2029)
3.4.3 North America Gentle Organic Infant Formula Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Gentle Organic Infant Formula Market Facts & Figures by Country
3.5.1 Europe Gentle Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Gentle Organic Infant Formula Sales by Country (2018-2029)
3.5.3 Europe Gentle Organic Infant Formula Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Gentle Organic Infant Formula Market Facts & Figures by Country
3.6.1 Asia Pacific Gentle Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Gentle Organic Infant Formula Sales by Country (2018-2029)
3.6.3 Asia Pacific Gentle Organic Infant Formula Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Gentle Organic Infant Formula Market Facts & Figures by Country
3.7.1 Latin America Gentle Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Gentle Organic Infant Formula Sales by Country (2018-2029)
3.7.3 Latin America Gentle Organic Infant Formula Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Gentle Organic Infant Formula Market Facts & Figures by Country
3.8.1 Middle East and Africa Gentle Organic Infant Formula Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Gentle Organic Infant Formula Sales by Country (2018-2029)
3.8.3 Middle East and Africa Gentle Organic Infant Formula Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Gentle Organic Infant Formula Sales by Type (2018-2029)
4.1.1 Global Gentle Organic Infant Formula Sales by Type (2018-2023)
4.1.2 Global Gentle Organic Infant Formula Sales by Type (2024-2029)
4.1.3 Global Gentle Organic Infant Formula Sales Market Share by Type (2018-2029)
4.2 Global Gentle Organic Infant Formula Revenue by Type (2018-2029)
4.2.1 Global Gentle Organic Infant Formula Revenue by Type (2018-2023)
4.2.2 Global Gentle Organic Infant Formula Revenue by Type (2024-2029)
4.2.3 Global Gentle Organic Infant Formula Revenue Market Share by Type (2018-2029)
4.3 Global Gentle Organic Infant Formula Price by Type (2018-2029)
5 Segment by Application
5.1 Global Gentle Organic Infant Formula Sales by Application (2018-2029)
5.1.1 Global Gentle Organic Infant Formula Sales by Application (2018-2023)
5.1.2 Global Gentle Organic Infant Formula Sales by Application (2024-2029)
5.1.3 Global Gentle Organic Infant Formula Sales Market Share by Application (2018-2029)
5.2 Global Gentle Organic Infant Formula Revenue by Application (2018-2029)
5.2.1 Global Gentle Organic Infant Formula Revenue by Application (2018-2023)
5.2.2 Global Gentle Organic Infant Formula Revenue by Application (2024-2029)
5.2.3 Global Gentle Organic Infant Formula Revenue Market Share by Application (2018-2029)
5.3 Global Gentle Organic Infant Formula Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Abbott Gentle Organic Infant Formula Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 HiPP
6.2.1 HiPP Corporation Information
6.2.2 HiPP Description and Business Overview
6.2.3 HiPP Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.2.4 HiPP Gentle Organic Infant Formula Product Portfolio
6.2.5 HiPP Recent Developments/Updates
6.3 Holle
6.3.1 Holle Corporation Information
6.3.2 Holle Description and Business Overview
6.3.3 Holle Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Holle Gentle Organic Infant Formula Product Portfolio
6.3.5 Holle Recent Developments/Updates
6.4 Bellamy
6.4.1 Bellamy Corporation Information
6.4.2 Bellamy Description and Business Overview
6.4.3 Bellamy Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bellamy Gentle Organic Infant Formula Product Portfolio
6.4.5 Bellamy Recent Developments/Updates
6.5 Topfer
6.5.1 Topfer Corporation Information
6.5.2 Topfer Description and Business Overview
6.5.3 Topfer Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Topfer Gentle Organic Infant Formula Product Portfolio
6.5.5 Topfer Recent Developments/Updates
6.6 Supermum
6.6.1 Supermum Corporation Information
6.6.2 Supermum Description and Business Overview
6.6.3 Supermum Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Supermum Gentle Organic Infant Formula Product Portfolio
6.6.5 Supermum Recent Developments/Updates
6.7 The Hain Celestial Group
6.6.1 The Hain Celestial Group Corporation Information
6.6.2 The Hain Celestial Group Description and Business Overview
6.6.3 The Hain Celestial Group Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.4.4 The Hain Celestial Group Gentle Organic Infant Formula Product Portfolio
6.7.5 The Hain Celestial Group Recent Developments/Updates
6.8 Nature One
6.8.1 Nature One Corporation Information
6.8.2 Nature One Description and Business Overview
6.8.3 Nature One Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Nature One Gentle Organic Infant Formula Product Portfolio
6.8.5 Nature One Recent Developments/Updates
6.9 Perrigo
6.9.1 Perrigo Corporation Information
6.9.2 Perrigo Description and Business Overview
6.9.3 Perrigo Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Perrigo Gentle Organic Infant Formula Product Portfolio
6.9.5 Perrigo Recent Developments/Updates
6.10 Babybio
6.10.1 Babybio Corporation Information
6.10.2 Babybio Description and Business Overview
6.10.3 Babybio Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Babybio Gentle Organic Infant Formula Product Portfolio
6.10.5 Babybio Recent Developments/Updates
6.11 Gittis
6.11.1 Gittis Corporation Information
6.11.2 Gittis Gentle Organic Infant Formula Description and Business Overview
6.11.3 Gittis Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Gittis Gentle Organic Infant Formula Product Portfolio
6.11.5 Gittis Recent Developments/Updates
6.12 Humana
6.12.1 Humana Corporation Information
6.12.2 Humana Gentle Organic Infant Formula Description and Business Overview
6.12.3 Humana Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Humana Gentle Organic Infant Formula Product Portfolio
6.12.5 Humana Recent Developments/Updates
6.13 Bimbosan
6.13.1 Bimbosan Corporation Information
6.13.2 Bimbosan Gentle Organic Infant Formula Description and Business Overview
6.13.3 Bimbosan Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Bimbosan Gentle Organic Infant Formula Product Portfolio
6.13.5 Bimbosan Recent Developments/Updates
6.14 Ausnutria
6.14.1 Ausnutria Corporation Information
6.14.2 Ausnutria Gentle Organic Infant Formula Description and Business Overview
6.14.3 Ausnutria Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Ausnutria Gentle Organic Infant Formula Product Portfolio
6.14.5 Ausnutria Recent Developments/Updates
6.15 Nutribio
6.15.1 Nutribio Corporation Information
6.15.2 Nutribio Gentle Organic Infant Formula Description and Business Overview
6.15.3 Nutribio Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Nutribio Gentle Organic Infant Formula Product Portfolio
6.15.5 Nutribio Recent Developments/Updates
6.16 HealthyTimes
6.16.1 HealthyTimes Corporation Information
6.16.2 HealthyTimes Gentle Organic Infant Formula Description and Business Overview
6.16.3 HealthyTimes Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.16.4 HealthyTimes Gentle Organic Infant Formula Product Portfolio
6.16.5 HealthyTimes Recent Developments/Updates
6.17 Arla
6.17.1 Arla Corporation Information
6.17.2 Arla Gentle Organic Infant Formula Description and Business Overview
6.17.3 Arla Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Arla Gentle Organic Infant Formula Product Portfolio
6.17.5 Arla Recent Developments/Updates
6.18 Angisland
6.18.1 Angisland Corporation Information
6.18.2 Angisland Gentle Organic Infant Formula Description and Business Overview
6.18.3 Angisland Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Angisland Gentle Organic Infant Formula Product Portfolio
6.18.5 Angisland Recent Developments/Updates
6.19 Yeeper
6.19.1 Yeeper Corporation Information
6.19.2 Yeeper Gentle Organic Infant Formula Description and Business Overview
6.19.3 Yeeper Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Yeeper Gentle Organic Infant Formula Product Portfolio
6.19.5 Yeeper Recent Developments/Updates
6.20 Wyeth
6.20.1 Wyeth Corporation Information
6.20.2 Wyeth Gentle Organic Infant Formula Description and Business Overview
6.20.3 Wyeth Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.20.4 Wyeth Gentle Organic Infant Formula Product Portfolio
6.20.5 Wyeth Recent Developments/Updates
6.21 Kendamil
6.21.1 Kendamil Corporation Information
6.21.2 Kendamil Gentle Organic Infant Formula Description and Business Overview
6.21.3 Kendamil Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.21.4 Kendamil Gentle Organic Infant Formula Product Portfolio
6.21.5 Kendamil Recent Developments/Updates
6.22 Nestle
6.22.1 Nestle Corporation Information
6.22.2 Nestle Gentle Organic Infant Formula Description and Business Overview
6.22.3 Nestle Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.22.4 Nestle Gentle Organic Infant Formula Product Portfolio
6.22.5 Nestle Recent Developments/Updates
6.23 Feihe
6.23.1 Feihe Corporation Information
6.23.2 Feihe Gentle Organic Infant Formula Description and Business Overview
6.23.3 Feihe Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.23.4 Feihe Gentle Organic Infant Formula Product Portfolio
6.23.5 Feihe Recent Developments/Updates
6.24 JUNLEBAO
6.24.1 JUNLEBAO Corporation Information
6.24.2 JUNLEBAO Gentle Organic Infant Formula Description and Business Overview
6.24.3 JUNLEBAO Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.24.4 JUNLEBAO Gentle Organic Infant Formula Product Portfolio
6.24.5 JUNLEBAO Recent Developments/Updates
6.25 YILI
6.25.1 YILI Corporation Information
6.25.2 YILI Gentle Organic Infant Formula Description and Business Overview
6.25.3 YILI Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.25.4 YILI Gentle Organic Infant Formula Product Portfolio
6.25.5 YILI Recent Developments/Updates
6.26 BIOSTIME
6.26.1 BIOSTIME Corporation Information
6.26.2 BIOSTIME Gentle Organic Infant Formula Description and Business Overview
6.26.3 BIOSTIME Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.26.4 BIOSTIME Gentle Organic Infant Formula Product Portfolio
6.26.5 BIOSTIME Recent Developments/Updates
6.27 Biobim
6.27.1 Biobim Corporation Information
6.27.2 Biobim Gentle Organic Infant Formula Description and Business Overview
6.27.3 Biobim Gentle Organic Infant Formula Sales, Revenue and Gross Margin (2018-2023)
6.27.4 Biobim Gentle Organic Infant Formula Product Portfolio
6.27.5 Biobim Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Gentle Organic Infant Formula Industry Chain Analysis
7.2 Gentle Organic Infant Formula Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Gentle Organic Infant Formula Production Mode & Process
7.4 Gentle Organic Infant Formula Sales and Marketing
7.4.1 Gentle Organic Infant Formula Sales Channels
7.4.2 Gentle Organic Infant Formula Distributors
7.5 Gentle Organic Infant Formula Customers
8 Gentle Organic Infant Formula Market Dynamics
8.1 Gentle Organic Infant Formula Industry Trends
8.2 Gentle Organic Infant Formula Market Drivers
8.3 Gentle Organic Infant Formula Market Challenges
8.4 Gentle Organic Infant Formula Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Abbott
HiPP
Holle
Bellamy
Topfer
Supermum
The Hain Celestial Group
Nature One
Perrigo
Babybio
Gittis
Humana
Bimbosan
Ausnutria
Nutribio
HealthyTimes
Arla
Angisland
Yeeper
Wyeth
Kendamil
Nestle
Feihe
JUNLEBAO
YILI
BIOSTIME
Biobim
Ìý
Ìý
*If Applicable.